Sphingolipids as targets for inhalation treatment of cystic fibrosis. (2018)
Attributed to:
Investigation into the role of ceramide in the pathogenesis of cystic fibrosis lung disease
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.addr.2018.04.015
PubMed Identifier: 29698625
Publication URI: http://europepmc.org/abstract/MED/29698625
Type: Journal Article/Review
Volume: 133
Parent Publication: Advanced drug delivery reviews
ISSN: 0169-409X